Tag Archives: First

Gilead’s Veklury becomes first FDA-approved drug for treating COVID-19

Dive Brief: The Food and Drug Administration has granted a full approval to Gilead’s COVID-19 drug Veklury, making it the first medicine to win a standard clearance from the agency to treat the disease caused by the new coronavirus. The FDA authorized Veklury for emergency use in May, a declaration that’s only valid during a… Read More »

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »

Healthcare sector added 358K jobs, hospitals had first gains in 2 months

Dive Brief: The healthcare sector added 358,000 jobs throughout the last two weeks of May and the first two weeks of June, according to the U.S. Bureau of Labor Statistics monthly jobs report. Similar to last month’s report, dentists and physician’s offices saw notable gains: 190,000 and 80,000 jobs added, respectively.​ Hospitals added about 7,000 jobs,… Read More »

CDC quietly revises coronavirus warnings on reopening religious sites, adds First Amendment note

U.S. President Donald Trump gives the podium to Centers for Disease Control (CDC) Director Robert Redfield to address the daily coronavirus disease (COVID-19) outbreak task force briefing at the White House in Washington, U.S. April 22, 2020. Jonathan Ernst | Reuters The Centers for Disease Control and Prevention quietly removed some of its warnings about… Read More »